Search

everythinglearnresearchcommunity

for

Search:↓

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Progesterone may help trans women with breast development and health, but more research is needed.

Menopausal hormone therapy can improve skin and hair health in menopausal women.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Testosterone is important for women's health, but more research is needed to guide its use.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Testosterone treatment may affect heart response to stress in transgender men.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Hormone therapy might help improve women's appearance as they age.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.